Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chronic cadmium (Cd) exposure can induce renal toxicity. In Cd renal toxicity,
p53
is thought to be involved. Our previous studies showed that Cd down-regulated gene expression of the UBE2D (ubiquitin-conjugating enzyme E2D) family members. Here, we aimed to define the association between UBE2D family members and
p53
-dependent apoptosis in human proximal tubular cells (HK-2 cells) treated with Cd. Cd increased intracellular
p53 protein
levels and decreased UBE2D2 and
UBE2D4
gene expression via inhibition of YY1 and FOXF1 transcription factor activities. Double knockdown of UBE2D2 and
UBE2D4
caused an increase in
p53 protein
levels, and knockdown of
p53
attenuated not only Cd-induced apoptosis, but also Cd-induced apoptosis-related gene expression (BAX and PUMA). Additionally, the mice exposed to Cd for 6 months resulted in increased levels of
p53
and induction of apoptosis in proximal tubular cells. These findings suggest that down-regulation of UBE2D family genes followed by accumulation of
p53
in proximal tubular cells is an important mechanism for Cd-induced renal toxicity.
...
PMID:Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity. 2691 77